DelveInsight’s “Alcohol Use Disorder Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Alcohol Use Disorder, historical and forecasted epidemiology as well as the Alcohol Use Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Alcohol Use Disorder market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Alcohol Use Disorder market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Alcohol Use Disorder Market Insights
Alcohol Use Disorder Overview
Alcohol Use Disorder is a medical condition characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences. It encompasses the conditions that some people refer to as alcohol abuse, alcohol dependence, alcohol addiction, and the colloquial term, alcoholism.
Some of the key facts of the Alcohol Use Disorder Market Report:
- The Alcohol Use Disorder market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
- According to the National Survey on Drug Use and Health (NSDUH), 14.5 million people aged 12 and older (5.3 percent of this age group) had AUD. This number includes 9.0 million men (6.8 percent of men) and 5.5 million women (3.9 percent of women)
- According to the National Center for Drug Abuse Statistics (NCDAS), 1-in-10 Americans over the age of 12 have Alcohol Use Disorder. Around 140,557 Americans die from the effects of alcohol in an average year. 10.2% of Americans aged 12 years and older had Alcohol Use Disorder. 1.7% of 12- to 17-year-olds have Alcohol Use Disorder
- Key Alcohol Use Disorder Companies: Pear Therapeutics, Cybin, Lohocla Research, BioXcel Therapeutics, Pop Test Oncology, Dicerna Pharmaceuticals, Astellas Pharma, Kinnov Therapeutics, MediciNova, Adial Pharmaceuticals, and others
- Key Alcohol Use Disorder Therapies: Pear-009, CYB003, Nezavist, BXCL501, PT150, DCR-AUD, ASP8062, KT 110, Ibudilast, AD04, and others
- The Alcohol Use Disorder epidemiology based on gender analyzed that males are more affected with Alcohol Use Disorder (AUD) as compared to females
Get a Free sample for the Alcohol Use Disorder Market Report –
https://www.delveinsight.com/sample-request/alcohol-use-disorder-market
Key benefits of the Alcohol Use Disorder Market report:
- Alcohol Use Disorder market report covers a descriptive overview and comprehensive insight of the Alcohol Use Disorder Epidemiology and Alcohol Use Disorder market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Alcohol Use Disorder market report provides insights on the current and emerging therapies.
- Alcohol Use Disorder market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Alcohol Use Disorder market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Alcohol Use Disorder market.
Download the report to understand which factors are driving Alcohol Use Disorder epidemiology trends @ Alcohol Use Disorder Epidemiological Insights
Alcohol Use Disorder Market
The dynamics of the Alcohol Use Disorder market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
“Alcohol use disorders are an important cause of morbidity and mortality. Despite the National Institute on Alcohol Abuse and Alcoholism (NIAAA) recommendations that medications be considered for patients with alcohol dependence, the mainstay of treatment has been counseling”
Alcohol Use Disorder Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Alcohol Use Disorder Epidemiology Segmentation:
The Alcohol Use Disorder market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Total Prevalence of Alcohol Use Disorder
- Prevalent Cases of Alcohol Use Disorder by severity
- Gender-specific Prevalence of Alcohol Use Disorder
- Diagnosed Cases of Episodic and Chronic Alcohol Use Disorder
Alcohol Use Disorder Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Alcohol Use Disorder market or expected to get launched during the study period. The analysis covers Alcohol Use Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Alcohol Use Disorder Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Discover more about therapies set to grab major Alcohol Use Disorder market share @ Alcohol Use Disorder market forecast
Alcohol Use Disorder Therapies and Key Companies
- Pear-009: Pear Therapeutics
- CYB003: Cybin
- Nezavist: Lohocla Research
- BXCL501: BioXcel Therapeutics
- PT150: Pop Test Oncology
- DCR-AUD: Dicerna Pharmaceuticals
- ASP8062: Astellas Pharma
- KT 110: Kinnov Therapeutics
- Ibudilast: MediciNova
- AD04: Adial Pharmaceuticals
Alcohol Use Disorder Pipeline Market Drivers
- Increasing Awareness
- Increasing research and development
- Initiative taken by market players
Scope of the Alcohol Use Disorder Market Report
- Study Period: 2019–2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Alcohol Use Disorder Companies: Pear Therapeutics, Cybin, Lohocla Research, BioXcel Therapeutics, Pop Test Oncology, Dicerna Pharmaceuticalsothers
- Key Alcohol Use Disorder Therapies: Pear-009, CYB003, Nezavist, BXCL501, PT150, DCR-AUD, ASP8062, KT 110, Ibudilast, AD04, and others
- Alcohol Use Disorder Therapeutic Assessment: Alcohol Use Disorder current marketed and Alcohol Use Disorder emerging therapies
- Alcohol Use Disorder Market Dynamics: Alcohol Use Disorder market drivers and Alcohol Use Disorder market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- Alcohol Use Disorder Unmet Needs, KOL’s views, Analyst’s views, Alcohol Use Disorder Market Access and Reimbursement
Alcohol Use Disorder Pipeline Market Barriers
- Less Treatment Side Effects of the Current Alcohol Use Disorder Therapies
Table of Contents
1. Alcohol Use Disorder Market Report Introduction
2. Executive Summary for Alcohol Use Disorder
3. SWOT analysis of Alcohol Use Disorder
4. Alcohol Use Disorder Patient Share (%) Overview at a Glance
5. Alcohol Use Disorder Market Overview at a Glance
6. Alcohol Use Disorder Disease Background and Overview
7. Alcohol Use Disorder Epidemiology and Patient Population
8. Country-Specific Patient Population of Alcohol Use Disorder
9. Alcohol Use Disorder Current Treatment and Medical Practices
10. Alcohol Use Disorder Unmet Needs
11. Alcohol Use Disorder Emerging Therapies
12. Alcohol Use Disorder Market Outlook
13. Country-Wise Alcohol Use Disorder Market Analysis (2019–2032)
14. Alcohol Use Disorder Market Access and Reimbursement of Therapies
15. Alcohol Use Disorder Market Drivers
16. Alcohol Use Disorder Market Barriers
17. Alcohol Use Disorder Appendix
18. Alcohol Use Disorder Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
To know more about Alcohol Use Disorder treatment, visit @ Alcohol Use Disorder Medications
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting